Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 6
2013 4
2014 6
2015 5
2016 2
2017 4
2018 3
2019 7
2020 6
2021 9
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Scherpereel A, Mazieres J, Greillier L, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, Audigier-Valette C, Locatelli-Sanchez M, Molinier O, Guisier F, Urban T, Ligeza-Poisson C, Planchard D, Amour E, Morin F, Moro-Sibilot D, Zalcman G; French Cooperative Thoracic Intergroup. Scherpereel A, et al. Among authors: bylicki o. Lancet Oncol. 2019 Feb;20(2):239-253. doi: 10.1016/S1470-2045(18)30765-4. Epub 2019 Jan 16. Lancet Oncol. 2019. PMID: 30660609 Clinical Trial.
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018.
Guisier F, Dubos-Arvis C, Viñas F, Doubre H, Ricordel C, Ropert S, Janicot H, Bernardi M, Fournel P, Lamy R, Pérol M, Dauba J, Gonzales G, Falchero L, Decroisette C, Assouline P, Chouaid C, Bylicki O. Guisier F, et al. Among authors: bylicki o. J Thorac Oncol. 2020 Apr;15(4):628-636. doi: 10.1016/j.jtho.2019.12.129. Epub 2020 Jan 13. J Thorac Oncol. 2020. PMID: 31945494 Free article.
An Outbreak of Covid-19 on an Aircraft Carrier.
Bylicki O, Paleiron N, Janvier F. Bylicki O, et al. N Engl J Med. 2021 Mar 11;384(10):976. doi: 10.1056/NEJMc2034424. Epub 2021 Feb 10. N Engl J Med. 2021. PMID: 33567182 No abstract available.
Factors associated with early lung cancer mortality: a systematic review.
Goussault H, Gendarme S, Assié JB, Bylicki O, Chouaïd C. Goussault H, et al. Among authors: bylicki o. Expert Rev Anticancer Ther. 2021 Oct;21(10):1125-1133. doi: 10.1080/14737140.2021.1941888. Epub 2021 Jun 30. Expert Rev Anticancer Ther. 2021. PMID: 34121578
[Tracheobronchomalacia in adults: breakthroughs and controversies].
Dutau H, Laroumagne S, Bylicki O, Vandemoortele T, Astoul P. Dutau H, et al. Among authors: bylicki o. Rev Mal Respir. 2012 Dec;29(10):1198-208. doi: 10.1016/j.rmr.2012.06.008. Epub 2012 Aug 2. Rev Mal Respir. 2012. PMID: 23228678 Review. French.
Targeted therapy for localized non-small-cell lung cancer: a review.
Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C. Paleiron N, et al. Among authors: bylicki o. Onco Targets Ther. 2016 Jul 5;9:4099-104. doi: 10.2147/OTT.S104938. eCollection 2016. Onco Targets Ther. 2016. PMID: 27462164 Free PMC article. Review.
[Respiratory distress of unusual cause].
de Charry C, Bylicki O, Mavrovi E, Le Moigne F, de Charry F. de Charry C, et al. Among authors: bylicki o. Rev Med Interne. 2018 Nov;39(11):894-895. doi: 10.1016/j.revmed.2017.06.013. Epub 2017 Jul 14. Rev Med Interne. 2018. PMID: 28716482 French. No abstract available.
48 results